Ovidio García (@ovidiogarciav) 's Twitter Profile
Ovidio García

@ovidiogarciav

Cardiac Surgery/ President of the Examination Board for Judiciary Experts at the Mexican College of Cardiovasc & Thorac Surgery/ National Academy ofMedicine Mex

ID: 791041274727936000

calendar_today25-10-2016 22:18:31

17,17K Tweet

3,3K Followers

2,2K Following

Ovidio García (@ovidiogarciav) 's Twitter Profile Photo

Getting back to running alongside my trusty sidekick Betsy, 5 months after meniscus fracture. Today we run 6 km. #run #running #runner #workout

Getting back to running alongside  my trusty sidekick Betsy, 5 months after meniscus fracture. Today we run 6 km. #run #running #runner #workout
Steve Greene (@sjgreene_md) 's Twitter Profile Photo

🚨 New #HeartFailure2025 #SimPub now in Journal of Cardiac Failure Prospective single-arm study from 🇺🇸 & 🇮🇳 shows: ✅feasibility of new remote-monitoring platform in 2 distinct countries ✅assoc improvements in #GDMTworks, #QoL, functional outcomes onlinejcf.com/article/S1071-…

🚨 New #HeartFailure2025 #SimPub now in <a href="/JCardFail/">Journal of Cardiac Failure</a>

Prospective single-arm study from 🇺🇸 &amp; 🇮🇳 shows:
✅feasibility of new remote-monitoring platform in 2 distinct countries
✅assoc improvements in #GDMTworks, #QoL, functional outcomes

onlinejcf.com/article/S1071-…
Ovidio García (@ovidiogarciav) 's Twitter Profile Photo

Mateo Marín-Cuartas Maurizio taramasso EJCTS_ICVTS Dr. Gilbert Tang Isaac George MD ArnarGeirssonMD Suzanne de Waha, MD Fabien Praz Tsuyoshi Kaneko Congrats! We need much more papers with longer follow-ups,because we’re entitled to know the official numbers(not only a ballpark figure) BEYOND 5 yr in M-TEER in #DMR (failure rate, not only reop). Let’s not be misled: #TEER has been available since 2003 (more than 20 years)‼️🚨

Ovidio García (@ovidiogarciav) 's Twitter Profile Photo

Victor Dayan Faisal Bakaeen MD Coronary 4Front Eduard Quintana Patrick Myers Rafa Sádaba John Mandrola, MD John P Erwin III MD MBA MACC (#BigPoppy ) theheartorg | Medscape Dear Victor Dayan, I agree with you 💯%. Nonetheless, remember that you can lead a horse to water, but you can’t make it drink. It’s outrageous but unfortunately this is how the cookie crumbles nowadays with a big deal of RCTs. That’s why the herd behavior is not a good idea.

Gaceta Médica de México (@gacetamedicamex) 's Twitter Profile Photo

✅Register yourself in TOC ALERT! ✅We will notify you every time we publish a new issue of #GacetaMedicaMex Suscribe here! 👉gacetamedicademexico.com/registration.p…

✅Register yourself in TOC ALERT!

✅We will notify you every time we publish a new issue of #GacetaMedicaMex 

Suscribe here!
👉gacetamedicademexico.com/registration.p…
Sanjay Kaul (@kaulcsmc) 's Twitter Profile Photo

abbott.mediaroom.com/2025-05-27-Abb… How many devices are approved by the FDA based on small (n<110), open-label, single-arm, non-randomized trial?

Sanjay Kaul (@kaulcsmc) 's Twitter Profile Photo

David J. Cohen, MD, MSc 42% of HDE devices from 1996-2017 according to an old report. Recent numbers are closer to 50%! In contrast 5-7% of drugs/biologics are approved based on single-arm trials.

Valva Mitralis (@mitrovalvology) 's Twitter Profile Photo

ACURATE neo2 valve versus commercially available transcatheter heart valves in patients with severe aortic stenosis (ACURATE IDE): a multicentre, randomised, controlled, non-inferiority trial #Lancet #ACURATEneo2 #ACURATEIDE #BostonScientific thelancet.com/journals/lance…

ACURATE neo2 valve versus commercially available transcatheter heart valves in patients with severe aortic stenosis (ACURATE IDE): a multicentre, randomised, controlled, non-inferiority trial  #Lancet  #ACURATEneo2 #ACURATEIDE #BostonScientific

thelancet.com/journals/lance…
Davide Capodanno (@dfcapodanno) 's Twitter Profile Photo

In the field of interventional cardiology, today’s news is that Boston Scientific Corporation has announced the discontinuation of global sales of its ACURATE neo2™ and ACURATE Prime™ aortic valve systems. Over the years, various iterations of this valve have been evaluated in

In the field of interventional cardiology, today’s news is that Boston Scientific Corporation has announced the discontinuation of global sales of its ACURATE neo2™ and ACURATE Prime™ aortic valve systems. Over the years, various iterations of this valve have been evaluated in
George Tolis (@georgetolisjr) 's Twitter Profile Photo

An aortic prosthesis placed in 1972 which I had to remove almost five decades later in order to gain access for an MVR. It was functioning perfectly. Open AVR on a young patient with a mechanical prosthesis through a full sternotomy is a great operation.

An aortic prosthesis placed in 1972 which I had to remove almost five decades later in order to gain access for an MVR. It was functioning perfectly. Open AVR on a young patient with a mechanical prosthesis through a full sternotomy is a great operation.
Ovidio García (@ovidiogarciav) 's Twitter Profile Photo

George Tolis Hands down it is, whether we like it or not, the best option heretofore for #AVR. We shouldn’t lost sight in the classic and traditional approaches, especially now, when a set of downright out-and-out nonsense alternatives are being offered in real-life off the record.